Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis

NCT02114931 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02114931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02114931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2014
Completion date
April 30, 2016
Enrollment
467 (actual)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid